5-159316780-C-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002187.3(IL12B):​c.892G>T​(p.Val298Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0268 in 1,614,030 control chromosomes in the GnomAD database, including 649 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 40 hom., cov: 33)
Exomes 𝑓: 0.027 ( 609 hom. )

Consequence

IL12B
NM_002187.3 missense

Scores

1
6
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.06
Variant links:
Genes affected
IL12B (HGNC:5970): (interleukin 12B) This gene encodes a subunit of interleukin 12, a cytokine that acts on T and natural killer cells, and has a broad array of biological activities. Interleukin 12 is a disulfide-linked heterodimer composed of the 40 kD cytokine receptor like subunit encoded by this gene, and a 35 kD subunit encoded by IL12A. This cytokine is expressed by activated macrophages that serve as an essential inducer of Th1 cells development. This cytokine has been found to be important for sustaining a sufficient number of memory/effector Th1 cells to mediate long-term protection to an intracellular pathogen. Overexpression of this gene was observed in the central nervous system of patients with multiple sclerosis (MS), suggesting a role of this cytokine in the pathogenesis of the disease. The promoter polymorphism of this gene has been reported to be associated with the severity of atopic and non-atopic asthma in children. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036674142).
BP6
Variant 5-159316780-C-A is Benign according to our data. Variant chr5-159316780-C-A is described in ClinVar as [Benign]. Clinvar id is 352572.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-159316780-C-A is described in Lovd as [Benign]. Variant chr5-159316780-C-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0212 (3224/152302) while in subpopulation NFE AF= 0.0304 (2067/68028). AF 95% confidence interval is 0.0293. There are 40 homozygotes in gnomad4. There are 1578 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 40 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
IL12BNM_002187.3 linkuse as main transcriptc.892G>T p.Val298Phe missense_variant 7/8 ENST00000231228.3 NP_002178.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
IL12BENST00000231228.3 linkuse as main transcriptc.892G>T p.Val298Phe missense_variant 7/81 NM_002187.3 ENSP00000231228 P1
IL12BENST00000696750.1 linkuse as main transcriptc.262G>T p.Val88Phe missense_variant 4/5 ENSP00000512849
IL12BENST00000696751.1 linkuse as main transcriptc.*387G>T 3_prime_UTR_variant, NMD_transcript_variant 6/7 ENSP00000512850
ENST00000521472.6 linkuse as main transcriptn.289+5366C>A intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.0212
AC:
3224
AN:
152184
Hom.:
40
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00610
Gnomad AMI
AF:
0.0274
Gnomad AMR
AF:
0.0289
Gnomad ASJ
AF:
0.0159
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.0291
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0304
Gnomad OTH
AF:
0.0244
GnomAD3 exomes
AF:
0.0207
AC:
5150
AN:
248422
Hom.:
81
AF XY:
0.0203
AC XY:
2721
AN XY:
134366
show subpopulations
Gnomad AFR exome
AF:
0.00527
Gnomad AMR exome
AF:
0.0209
Gnomad ASJ exome
AF:
0.0152
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00242
Gnomad FIN exome
AF:
0.0303
Gnomad NFE exome
AF:
0.0300
Gnomad OTH exome
AF:
0.0207
GnomAD4 exome
AF:
0.0273
AC:
39960
AN:
1461728
Hom.:
609
Cov.:
32
AF XY:
0.0263
AC XY:
19159
AN XY:
727160
show subpopulations
Gnomad4 AFR exome
AF:
0.00508
Gnomad4 AMR exome
AF:
0.0217
Gnomad4 ASJ exome
AF:
0.0164
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00254
Gnomad4 FIN exome
AF:
0.0290
Gnomad4 NFE exome
AF:
0.0316
Gnomad4 OTH exome
AF:
0.0236
GnomAD4 genome
AF:
0.0212
AC:
3224
AN:
152302
Hom.:
40
Cov.:
33
AF XY:
0.0212
AC XY:
1578
AN XY:
74470
show subpopulations
Gnomad4 AFR
AF:
0.00609
Gnomad4 AMR
AF:
0.0288
Gnomad4 ASJ
AF:
0.0159
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00290
Gnomad4 FIN
AF:
0.0291
Gnomad4 NFE
AF:
0.0304
Gnomad4 OTH
AF:
0.0241
Alfa
AF:
0.0286
Hom.:
162
Bravo
AF:
0.0210
TwinsUK
AF:
0.0289
AC:
107
ALSPAC
AF:
0.0298
AC:
115
ESP6500AA
AF:
0.00567
AC:
25
ESP6500EA
AF:
0.0303
AC:
261
ExAC
AF:
0.0205
AC:
2485
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.0286
EpiControl
AF:
0.0313

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.38
T
Eigen
Uncertain
0.41
Eigen_PC
Uncertain
0.31
FATHMM_MKL
Benign
0.33
N
LIST_S2
Benign
0.75
T
MetaRNN
Benign
0.0037
T
MetaSVM
Benign
-0.56
T
MutationAssessor
Pathogenic
3.2
M
MutationTaster
Benign
0.56
D
PrimateAI
Benign
0.47
T
PROVEAN
Uncertain
-2.4
N
REVEL
Benign
0.13
Sift
Uncertain
0.021
D
Sift4G
Uncertain
0.0050
D
Polyphen
0.98
D
Vest4
0.24
MPC
0.90
ClinPred
0.066
T
GERP RS
5.7
Varity_R
0.64
gMVP
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3213119; hg19: chr5-158743788; API